149 related articles for article (PubMed ID: 31753388)
1. Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy.
Xia Y; Xiao M; Zhao M; Xu T; Guo M; Wang C; Li Y; Zhu B; Liu H
Mater Sci Eng C Mater Biol Appl; 2020 Jan; 106():110100. PubMed ID: 31753388
[TBL] [Abstract][Full Text] [Related]
2. Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy.
Xia Y; Xu T; Wang C; Li Y; Lin Z; Zhao M; Zhu B
Int J Nanomedicine; 2018; 13():143-159. PubMed ID: 29317822
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic Acid-Bilirubin Nanoparticles as a Tumor Microenvironment Reactive Oxygen Species-Responsive Nanomedicine for Targeted Cancer Therapy.
Lee S; Lee SA; Shinn J; Lee Y
Int J Nanomedicine; 2024; 19():4893-4906. PubMed ID: 38828202
[TBL] [Abstract][Full Text] [Related]
4. Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy.
Wang C; Xia Y; Huo S; Shou D; Mei Q; Tang W; Li Y; Liu H; Zhou Y; Zhu B
Int J Nanomedicine; 2020; 15():9759-9770. PubMed ID: 33304100
[TBL] [Abstract][Full Text] [Related]
5. siRNA-loaded selenium nanoparticle modified with hyaluronic acid for enhanced hepatocellular carcinoma therapy.
Xia Y; Guo M; Xu T; Li Y; Wang C; Lin Z; Zhao M; Zhu B
Int J Nanomedicine; 2018; 13():1539-1552. PubMed ID: 29588583
[TBL] [Abstract][Full Text] [Related]
6. GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways.
Pi J; Jiang J; Cai H; Yang F; Jin H; Yang P; Cai J; Chen ZW
Drug Deliv; 2017 Nov; 24(1):1549-1564. PubMed ID: 29019267
[TBL] [Abstract][Full Text] [Related]
7. Enhanced antitumor activity of doxorubicin in breast cancer through the use of poly(butylcyanoacrylate) nanoparticles.
Cabeza L; Ortiz R; Arias JL; Prados J; Ruiz Martínez MA; Entrena JM; Luque R; Melguizo C
Int J Nanomedicine; 2015; 10():1291-306. PubMed ID: 25709449
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of biocompatible nanocrystalline cellulose against folate receptors as a novel carrier for targeted delivery of doxorubicin.
Karimian A; Yousefi B; Sadeghi F; Feizi F; Najafzadehvarzi H; Parsian H
Chem Biol Interact; 2022 Jan; 351():109731. PubMed ID: 34728188
[TBL] [Abstract][Full Text] [Related]
9. Biotin anchored nanostructured lipid carriers for targeted delivery of doxorubicin in management of mammary gland carcinoma through regulation of apoptotic modulator.
Tripathi CB; Parashar P; Arya M; Singh M; Kanoujia J; Kaithwas G; Saraf SA
J Liposome Res; 2020 Mar; 30(1):21-36. PubMed ID: 30741049
[TBL] [Abstract][Full Text] [Related]
10. Protein-Gated Upconversion Nanoparticle-Embedded Mesoporous Silica Nanovehicles via Diselenide Linkages for Drug Release Tracking in Real Time and Tumor Chemotherapy.
Yan H; Dong J; Huang X; Du X
ACS Appl Mater Interfaces; 2021 Jun; 13(24):29070-29082. PubMed ID: 34101411
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells.
Vyas D; Lopez-Hisijos N; Gandhi S; El-Dakdouki M; Basson MD; Walsh MF; Huang X; Vyas AK; Chaturvedi LS
J Nanosci Nanotechnol; 2015 Sep; 15(9):6413-22. PubMed ID: 26690867
[TBL] [Abstract][Full Text] [Related]
12. Tumor-targeted and stimulus-responsive polymeric prodrug nanoparticles to enhance the anticancer therapeutic efficacy of doxorubicin.
Kim N; Kwon S; Kwon G; Song N; Jo H; Kim C; Park S; Lee D
J Control Release; 2024 May; 369():351-362. PubMed ID: 38552963
[TBL] [Abstract][Full Text] [Related]
13. Turmeric Extract-loaded Selenium Nanoparticles Counter Doxorubicin-induced Hepatotoxicity in Mice
ALRashdi BM; Hussein MM; Mohammed RM; Abdelhamed NW; Asaad ME; Alruwaili M; Alrashidi SM; Habotta OA; Abdel Moneim AE; Ramadan SS
Anticancer Agents Med Chem; 2024; 24(6):443-453. PubMed ID: 38204261
[TBL] [Abstract][Full Text] [Related]
14. A Unique Approach: Biomimetic Graphdiyne-Based Nanoplatform to Treat Prostate Cancer by Combining Cuproptosis and Enhanced Chemodynamic Therapy.
Xie W; Zhang Y; Xu Q; Zhong G; Lin J; He H; Du Q; Tan H; Chen M; Wu Z; Deng Y; Han Z; Lu J; Ye J; Zou F; Zhuo Y; Zhong W
Int J Nanomedicine; 2024; 19():3957-3972. PubMed ID: 38711614
[TBL] [Abstract][Full Text] [Related]
15. Promotion of initial anti-tumor effect via polydopamine modified doxorubicin-loaded electrospun fibrous membranes.
Yuan Z; Zhao X; Wang X; Qiu W; Chen X; Zheng Q; Cui W
Int J Clin Exp Pathol; 2014; 7(9):5436-49. PubMed ID: 25337186
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of Combination Therapy with Linalool and Doxorubicin Encapsulated by Liposomes as a Two-in-One Hybrid Carrier System for Epithelial Ovarian Carcinoma.
Wi TI; Won JE; Lee CM; Lee JW; Kang TH; Shin BC; Han HD; Park YM
Int J Nanomedicine; 2020; 15():8427-8436. PubMed ID: 33149585
[TBL] [Abstract][Full Text] [Related]
17. Cancer Cell-Membrane Biomimetic Boron Nitride Nanospheres for Targeted Cancer Therapy.
Feng S; Ren Y; Li H; Tang Y; Yan J; Shen Z; Zhang H; Chen F
Int J Nanomedicine; 2021; 16():2123-2136. PubMed ID: 33731994
[TBL] [Abstract][Full Text] [Related]
18. Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles.
Li H; Xu W; Li F; Zeng R; Zhang X; Wang X; Zhao S; Weng J; Li Z; Sun L
Drug Deliv; 2022 Dec; 29(1):192-202. PubMed ID: 34984953
[TBL] [Abstract][Full Text] [Related]
19. Assessing the in vivo efficacy of doxorubicin loaded hyaluronan nanoparticles.
El-Dakdouki MH; Xia J; Zhu DC; Kavunja H; Grieshaber J; O'Reilly S; McCormick JJ; Huang X
ACS Appl Mater Interfaces; 2014 Jan; 6(1):697-705. PubMed ID: 24308364
[TBL] [Abstract][Full Text] [Related]
20. Raspberry-like poly(γ-glutamic acid) hydrogel particles for pH-dependent cell membrane passage and controlled cytosolic delivery of antitumor drugs.
Cho SH; Hong JH; Noh YW; Lee E; Lee CS; Lim YT
Int J Nanomedicine; 2016; 11():5621-5632. PubMed ID: 27822040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
